Expression of Concern: The haptoglobin beta subunit sequesters HMGB1 toxicity in sterile and infectious inflammation (Journal of Internal Medicine, (2017), 282, 1, (76-93), 10.1111/joim.12619);The haptoglobin beta subunit sequesters HMGB1 toxicity in sterile and infectious inflammation

Journal of Internal Medicine

Volumn 282, Issue 1, 2017, Pages 76-93

  Yang, H ^a   Wang, H ^a   Wang, Y ^a   Addorisio, M ^a   Li, J ^a   Postiglione, M J ^a   Chavan, S S ^a   Al Abed, Y ^a   Antoine, D J ^b   Andersson, U ^c   Tracey, K J ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

acetaminophen intoxication; CD163; cytokine; haptoglobin ( ); HMGB1; sepsis

Indexed keywords

ANTIINFECTIVE AGENT; CD163 ANTIGEN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HAPTOGLOBIN; HAPTOGLOBIN BETA SUBUNIT; HEME OXYGENASE 1; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIVER PROTECTIVE AGENT; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; PARACETAMOL; RECOMBINANT HAPTOGLOBIN BETA SUBUNIT; RECOMBINANT HIGH MOBILITY GROUP B1 PROTEIN; RECOMBINANT PROTEIN; RNA 18S; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; CYTOKINE; DIFFERENTIATION ANTIGEN; HMOX1 PROTEIN, HUMAN; HP PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CONTROLLED STUDY; CYTOKINE RELEASE; DISULFIDE BOND; EXPERIMENTAL PERITONITIS; HUMAN; HUMAN CELL; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TOXIC HEPATITIS; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CHEMICAL AND DRUG INDUCED LIVER INJURY; DISEASE MODEL; MACROPHAGE; METABOLISM; SEPSIS;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELLS, CULTURED; CHEMICAL AND DRUG INDUCED LIVER INJURY; CYTOKINES; DISEASE MODELS, ANIMAL; HAPTOGLOBINS; HEME OXYGENASE-1; HMGB1 PROTEIN; HUMANS; INTERLEUKIN-10; MACROPHAGES; MALE; MICE, INBRED C57BL; PROTEIN BINDING; RECEPTORS, CELL SURFACE; SEPSIS;

EID: 85020063130     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12906     Document Type: Erratum

References (53)

1. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001; 29: S109–16.
2. Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 2012; 40: 754–61.
3. Deutschman CS, Tracey KJ. Sepsis: current dogma and new perspectives. Immunity 2014; 40: 463–75.
4. Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 2011; 29: 139–62.
5. Tsung A, Tohme S, Billiar TR. High-mobility group box-1 in sterile inflammation. J Intern Med 2014; 276: 425–43.
6. Tang D, Kang R, Livesey KM et al. Endogenous HMGB1 regulates autophagy. J Cell Biol 2010; 190: 881–92.
7. Zhu X, Messer JS, Wang Y et al. Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation. J Clin Invest 2015; 125: 1098–110.
8. Yang H, Antoine DJ, Andersson U, Tracey KJ. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol 2013; 93: 865–73.
9. Kristiansen M, Graversen JH, Jacobsen C et al. Identification of the haemoglobin scavenger receptor. Nature 2001; 409: 198–201.
10. Yang H, Wang H, Levine YA et al. Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes. JCI Insight 2016; 1: e85375.
11. Yueh SC, Lai YA, Chen WL, Hsu HH, Mao SJ. An improved method for haptoglobin 1-1, 2-1, and 2-2 purification using monoclonal antibody affinity chromatography in the presence of sodium dodecyl sulfate. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 845: 210–7.
12. Wang H, Bloom O, Zhang M et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science (New York, NY) 1999; 285: 248–51.
13. Li J, Wang H, Mason JM et al. Recombinant HMGB1 with cytokine-stimulating activity. J Immunol Methods 2004; 289: 211–23.
14. Yang H, Lundback P, Ottosson L et al. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med 2012; 18: 250–9.
15. Yang H, Wang H, Ju Z et al. MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. J Exp Med 2015; 212: 5–14.
16. Tian J, Avalos AM, Mao SY et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007; 8: 487–96.
17. Moreno JA, Munoz-Garcia B, Martin-Ventura JL et al. The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis. Atherosclerosis 2009; 207: 103–10.
18. Gao S, Wang L, Liu W, Wu Y, Yuan Z. The synergistic effect of homocysteine and lipopolysaccharide on the differentiation and conversion of raw264.7 macrophages. J Inflamm (Lond) 2014; 11: 13.
19. Yamazaki T, Mori M, Arai S et al. Circulating AIM as an indicator of liver damage and hepatocellular carcinoma in humans. PLoS ONE 2014; 9: e109123.
20. Zhang GX, Yu S, Gran B et al. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis. J Immunol (Baltimore, Md: 1950) 2003; 171: 4485–92.
21. Bouhlel MA, Derudas B, Rigamonti E et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007; 6: 137–43.
22. Kiselak EA, Shen X, Song J et al. Transcriptional regulation of an axonemal central apparatus gene, sperm-associated antigen 6, by a SRY-related high mobility group transcription factor, S-SOX5. J Biol Chem 2010; 285: 30496–505.
23. Saenz R, Futalan D, Leutenez L et al. TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant. J Transl Med 2014; 12: 211.
24. Yang H, Tracey KJ. Targeting HMGB1 in inflammation. Biochem Biophys Acta 2010; 1799: 149–56.
25. Choi HW, Tian M, Song F et al. Aspirin's active metabolite salicylic acid targets high mobility group Box 1 to modulate inflammatory responses. Mol Med 2015; 21: 526–35.
26. Yang H, Ochani M, Li J et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004; 101: 296–301.
27. Arredouani MS, Kasran A, Vanoirbeek JA, Berger FG, Baumann H, Ceuppens JL. Haptoglobin dampens endotoxin-induced inflammatory effects both in vitro and in vivo. Immunology 2005; 114: 263–71.
28. Qin S, Wang H, Yuan R et al. Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med 2006; 203: 1637–42.
29. Antoine DJ, Jenkins RE, Dear JW et al. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol 2012; 56: 1070–9.
30. Desmet VJ, Knodell RG, Ishak KG et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. J Hepatol 2003; 38: 382–6.
31. Wejman JC, Hovsepian D, Wall JS, Hainfeld JF, Greer J. Structure of haptoglobin and the haptoglobin-hemoglobin complex by electron microscopy. J Mol Biol 1984; 174: 319–41.
32. Antoine DJ, Harris HE, Andersson U, Tracey KJ, Bianchi ME. A systematic nomenclature for the redox states of high mobility group box (HMGB) proteins. Mol Med 2014; 20: 135–7.
33. Porcheray F, Viaud S, Rimaniol AC et al. Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 2005; 142: 481–9.
34. Su Z, Zhang P, Yu Y et al. HMGB1 facilitated macrophage reprogramming towards a proinflammatory M1-like phenotype in experimental autoimmune myocarditis development. Sci Rep 2016; 6: 21884.
35. Xu J, Jiang Y, Wang J et al. Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis. Cell Death Differ 2014; 21: 1229–39.
36. Antoine DJ, Williams DP, Kipar A, Laverty H, Park BK. Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity. Mol Med 2010; 16: 479–90.
37. Lea JD, Clarke JI, McGuire N, Antoine DJ. Redox-dependent HMGB1 isoforms as pivotal co-ordinators of drug-induced liver injury: mechanistic biomarkers and therapeutic targets. Antioxid Redox Signal 2016; 24: 652–65.
38. Sodhi CP, Jia H, Yamaguchi Y et al. Intestinal epithelial TLR-4 activation is required for the development of acute lung injury after trauma/hemorrhagic shock via the release of HMGB1 from the gut. J Immunol (Baltimore, Md: 1950) 2015; 194: 4931–9.
39. Lim SK, Kim H, Bin Ali A et al. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood 1998; 92: 1870–7.
40. Barros MH, Hauck F, Dreyer JH, Kempkes B, Niedobitek G. Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS ONE 2013; 8: e80908.
41. Karuppagounder V, Giridharan VV, Arumugam S et al. Modulation of macrophage polarization and HMGB1-TLR2/TLR4 cascade plays a crucial role for cardiac remodeling in senescence-accelerated prone mice. PLoS ONE 2016; 11: e0152922.
42. Tian S, Zhang L, Tang J, Guo X, Dong K, Chen SY. HMGB1 exacerbates renal tubulointerstitial fibrosis through facilitating M1 macrophage phenotype at the early stage of obstructive injury. Am J Physiol Renal Physiol 2015; 308: F69–75.
43. Nielsen MJ, Moestrup SK. Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood 2009; 114: 764–71.
44. Nielsen MJ, Petersen SV, Jacobsen C et al. A unique loop extension in the serine protease domain of haptoglobin is essential for CD163 recognition of the haptoglobin-hemoglobin complex. J Biol Chem 2007; 282: 1072–9.
45. Andersen CBF, Torvund-Jensen M, Nielsen MJ et al. Structure of the haptoglobin-haemoglobin complex. Nature 2012; 489: 456–9.
46. Melamed-Frank M, Lache O, Enav BI et al. Structure-function analysis of the antioxidant properties of haptoglobin. Blood 2001; 98: 3693–8.
47. Peacock AC, Gelderman AH, Ragland RH, Hoffman HA. Haptoglobin levels in serum of various strains of mice. Science (New York, NY) 1967; 158: 1703–4.
48. Etzerodt A, Kjolby M, Nielsen MJ, Maniecki M, Svendsen P, Moestrup SK. Plasma clearance of hemoglobin and haptoglobin in mice and effect of CD163 gene targeting disruption. Antioxid Redox Signal 2013; 18: 2254–63.
49. Boretti FS, Buehler PW, D'Agnillo F et al. Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs. J Clin Invest 2009; 119: 2271–80.
50. Nielsen MJ, Andersen CB, Moestrup SK. CD163 binding to haptoglobin-hemoglobin complexes involves a dual-point electrostatic receptor-ligand pairing. J Biol Chem 2013; 288: 18834–41.
51. Irwin DC, Baek JH, Hassell K et al. Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration. Free Radic Biol Med 2015; 82: 50–62.
52. Schaer CA, Laczko E, Schoedon G, Schaer DJ, Vallelian F. Chloroquine interference with hemoglobin endocytic trafficking suppresses adaptive heme and iron homeostasis in macrophages: the paradox of an antimalarial agent. Oxid Med Cell Longev 2013; 2013: 870472.
53. Schaer DJ, Vinchi F, Ingoglia G, Tolosano E, Buehler PW. Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development. Front Physiol 2014; 5: 415.